<DOC>
	<DOCNO>NCT00352976</DOCNO>
	<brief_summary>This single arm , total body irradiation ( TBI ) trial . All patient prescribe TBI 300 cGy goal evaluate secondary endpoint .</brief_summary>
	<brief_title>TBI Dose De-escalation Fanconi Anemia</brief_title>
	<detailed_description>Study Treatment : Patients receive voriconazole ( antifungal therapy ) mouth begin 1 month prior condition therapy , possible . 1 ) The subject receive total body irradiation ( 300 cGy ) thymic shielding ; give six day stem cell give ( day -6 ) . 2 ) Day -5 Day -2 , subject receive chemotherapy regimen Fludarabine Cyclophosphamide via central line ( i.e . Hickman Broviac ) . Starting Day -3 , patient receive sirolimus therapy taper commence day +180 also mycophenolate mofetil ( MMF ) day +30 7 day engraftment , whichever day later , acute graft-versus-host disease ( GVHD ) . 4 ) If subject receive bone marrow `` peripheral '' stem cell ( cell collect donor 's arm via cell separator ) , day transplantation , stem cell take donor put machine separate lymphocyte ( cell cause graft-versus-host disease [ GVHD ] ) stem cell . If subject receive umbilical cord blood , lymphocytes remove risk GVHD high . Otherwise patient receive treatment . The stem cell give infusion subject 's exist catheter 1-2 hour day 0.5 . On day transplant ( day +1 ) subject give G-CSF stimulate growth transplant cell . 6 . While receive treatment subject 's blood count recover he/she daily blood test , several bone marrow biopsy aspirate . After recovery , subject see month health assessment blood test least 3 month cell infuse . Additional blood test assessment may do medically indicate .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Fanconi Syndrome</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Meeting definition standard risk high risk Fanconi anemia define next two section : Standard risk patient must &lt; 18 year age diagnosis Fanconi anemia aplastic anemia ( AA ) , myelodysplastic syndrome without excess blast , high risk genotype define : Aplastic anemia define least one follow receive growth factor transfusion : platelet count &lt; 20 * 10^9/L ANC &lt; 5 * 10^8/L Hemoglobin &lt; 8 g/dL Myelodysplastic syndrome ( MDS ) multilineage dysplasia without chromosomal anomaly High risk genotype ( e.g . IVS4 exon 14 FANCC mutation , BRCA1 2 mutation ) High risk patient must one follow high risk feature : Advanced MDS ( ≥ 5 % blast ) acute leukemia Require additional HSCT graft failure History time systemic fungal gram negative infection Severe renal disease creatinine clearance &lt; 40 mL/min Age &gt; 18 year Very high risk patient must Advanced MDS ( ≥ 5 % blast ) acute leukemia initial hematopoietic stem cell transplant ( HSCT ) Patients must appropriate source stem cell . Patients donor type HLAA , B , C DRB1 use high resolution molecular typing . Adequate major organ function include : Cardiac : ejection fraction &gt; 45 % Hepatic : bilirubin , AST ALT , ALP &lt; 5 x normal Karnofsky performance status &gt; 70 % Lansky &gt; 50 ( &lt; 16 year age ) Women childbearing age must use adequate birth control negative pregnancy test . Written consent . Available HLAgenotypically identical relate donor standard risk patient . Active central nervous system ( CNS ) leukemia time study enrollment . History squamous cell carcinoma head/neck/cervix within previous 2 year . Prior radiation therapy prevents total body irradiation ( TBI ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bone Marrow transplant</keyword>
	<keyword>stem cell transplant</keyword>
	<keyword>cord blood transplant</keyword>
	<keyword>total body irradiation</keyword>
	<keyword>thymic shielding</keyword>
</DOC>